Ionis Pharmaceuticals (IONS) Long-Term Investments (2010 - 2012)

Ionis Pharmaceuticals' Long-Term Investments history runs 3 years deep, the most recent figure standing at -$5.6 million for Q3 2012.

• In Q3 2012, Long-Term Investments fell 76.88% year-over-year to -$5.6 million; the TTM figure through Sep 2012 stood at -$5.6 million (down 76.88% YoY), while the FY2011 annual figure was -$4.4 million, down 408.51% from the prior year.
• Long-Term Investments was -$5.6 million for Q3 2012 at Ionis Pharmaceuticals, roughly flat from -$5.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of -$870000.0 in Q4 2010 to a low of -$5.6 million in Q2 2012.
• Historically, Long-Term Investments has averaged -$3.9 million across 3 years, with a median of -$4.2 million in 2010.
• Biggest YoY gain for Long-Term Investments was 37.1% in 2011; the steepest drop was 408.51% in 2011.
• A 3-year view of Long-Term Investments shows it stood at -$870000.0 in 2010, then slumped by 408.51% to -$4.4 million in 2011, then fell by 25.75% to -$5.6 million in 2012.
• The last three Long-Term Investments figures came in at -$5.6 million (Q3 2012), -$5.6 million (Q2 2012), and -$5.4 million (Q1 2012), per Business Quant data.